Log In
BCIQ
Print this Print this
 

AVA-322

  Manage Alerts
Collapse Summary General Information
Company Adverum Biotechnologies Inc.
DescriptionGene therapy product carrying the gene for L-opsin
Molecular Target
Mechanism of ActionGene therapy
Therapeutic ModalityGene therapy
Latest Stage of DevelopmentPreclinical
Standard IndicationBlindness
Indication DetailsTreat color vision deficiency or red-green color blindness; Treat protan defects
Regulatory Designation
Partner

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
Total Number of DealsTotal Deal ValueTotal Upfront CashTotal Milestone Payments

1

0

0

0


 Deals Details
DateCompanies InvolvedDeal HeadlineTotal Deal ValueTotal Upfront CashTotal Milestone

03/25/2015

Undisclosed

Undisclosed

Undisclosed

Get a free BioCentury trial today